SCHEMBL6733910

SCHEMBL6733910

CCC1(Cc2ccccc2)CCCN(Cc2ccccc2)C1=O

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.62
MEN1 O00255 1/20 0.62
HCRTR1 O43613 5/20 0.46
HCRTR2 O43614 5/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ELANE P08246 3/20 0.44
DDB1 Q16531 1/20 0.42
CRBN Q96SW2 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
RIPK1 Q13546 1/20 0.40
OPRM1 P35372 1/20 0.39
OPRL1 P41146 1/20 0.39
CYP2D6 P10635 3/20 0.39
CYP3A4 P08684 2/20 0.39
TSHR P16473 2/20 0.39
POLB P06746 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7046375 0.93 KMT2A (0.68) KMT2AMEN1HCRTR1HCRTR2L3MBTL1
SCHEMBL6733707 0.92 KMT2A (0.54) KMT2AMEN1HCRTR1HCRTR2L3MBTL1
SCHEMBL7954875 0.84 KMT2A (0.59) KMT2AMEN1HCRTR1HCRTR2L3MBTL1
SCHEMBL6727270 0.83 ELANE (0.48) KMT2AMEN1ELANENPSR1OPRM1
SCHEMBL7954267 0.82 KMT2A (0.54) KMT2AMEN1HCRTR1HCRTR2L3MBTL1
SCHEMBL6732110 0.80 KMT2A (0.66) KMT2AMEN1HCRTR1HCRTR2L3MBTL1
SCHEMBL6734594 0.80 KMT2A (0.66) KMT2AMEN1HCRTR1HCRTR2L3MBTL1
SCHEMBL9726979 0.77 KMT2A (1.00) KMT2AMEN1HCRTR1HCRTR2L3MBTL1
SCHEMBL7947400 0.77 KMT2A (0.48) KMT2AMEN1HCRTR1HCRTR2L3MBTL1
SCHEMBL7947397 0.77 MEN1 (0.48) KMT2AMEN1HCRTR1HCRTR2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6680331-B2 ADMINISTERING DIETHYL LACTAMS SUCH AS 3,3-DIETHYL-2-PYRROLIDINONE FOR INDUCING ANESTHESIA OR CONSCIOUS SEDATION BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2004-01-20 US disclosed
US-20030078283-A1 Lactam and thiolactam derivatives as anesthetic and conscious sedation agents BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2003-04-24 US disclosed
US-6066666-A OPTIONALLY N-SUBSTITUTED 3-MONO- AND DI-SUBSTITUTED 2-PYRROLIDINONES AND THIOLACTAM ANALOGS; TREAT SEIZURES, ANXIETY, AND ENHANCING 4-AMINOBUTYRIC ACID (GABA)-INDUCED CHLORIDE CURRENTS AT GABA RECEPTOR/IONOPHORE COMPLEX WASHINGTON UNIVERSITY (US) 2000-05-23 US disclosed
US-5776959-A Anticonvulsant and anxiolytic lactam and thiolactam derivatives WASHINGTON UNIVERSITY (US) 1998-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078283-A1 Lactam and thiolactam derivatives as anesthetic and conscious sedation agents GABRD, GABRE, CCT8 KMT2A 1218/4885MEN1 3305/4885HCRTR1 3800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.